Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BY-NC-ND 4.0Animal Models and Experimental Medicine

The potency of native postbiotics and paraprobiotics in modulating inflammation by affecting the gut–kidney axis

  1. 1Department of Bacteriology Pasteur Institute of Iran Tehran Iran
  2. 2Clinical Research Department Pasteur Institute of Iran Tehran Iran
  3. 3Department of Biology, To.C. Islamic Azad University Tonekabon Iran

Abstract

Background: The gut's impact on kidney health can be observed through its influence on the gut–kidney axis. However, using paraprobiotic and postbiotic agents may improve gut health and kidney function by affecting signaling pathways. This study aims to assess the anti‐inflammatory and autophagy‐inducing properties of native postbiotics and paraprobiotics to enhance kidney health by targeting the gut–kidney axis.

Methods: In this animal experiment, colitis was induced in male C57Bl/6 mice using dextran sulfate sodium (DSS), and mice were treated with postbiotics and paraprobiotics consisting of four Lactobacillus and two Bifidobacterium strains. A quantitative polymerase chain reaction assay was conducted to evaluate the gene expression involved in the autophagy process in the kidney.

Results: A significant decrease in weight and colon length and an increase in disease activity index and pathological changes were observed in the DSS group. However, the paraprobiotic and postbiotic mixtures, with more emphasis on postbiotics, were effective in preventing these changes caused by DSS. Exposure to DSS resulted in the downregulation of autophagy‐related genes, but this difference was not statistically significant. Both the paraprobiotics and postbiotics increased the expression of genes. The postbiotic mixture had a more pronounced effect in increasing the expression of atg7, atg12, and beclin.

Conclusions: Our native postbiotics and paraprobiotics indicated an effective role in reducing inflammation, especially gut and kidney inflammation, through the gut–kidney axis. The administration of these beneficial agents with the least side effects could be considered a suitable complementary treatment for controlling symptoms in patients with inflammatory‐related disease.

Related

  1. Immunomodulatory effects of postbiotics derived from Lacticaseibacillus casei strain RIGLD MG-1 on Helicobacter pylori-induced inflammation in gastric epithelial cells in vitro
    Masoomeh Ghasemipoor, Mohammad Yaghoubi-Avini, Michael Doulberis +3
    Scientific ReportsPeer-reviewedCC BY 4.0Crossref
  2. Euscaphic Acid from Rosa roxburghii Tratt Fruit Ameliorates Ulcerative Colitis by Modulating Oxidative Stress, Inflammation, Gut Microbiota, and Metabolism
    Foods (Basel, Switzerland)Peer-reviewedCC BYFull textEurope PMC
  3. Kaempferol-3-O-Rutinoside (K3R) Promotes Functional Rehabilitation by Modulating S100β and Inflammation Following Induced Traumatic Injury to Sciatic Nerve in Mouse Model
    Tehreem Iman, Humaira Muzaffar, Muhammad Zubair +1
    Brain sciencesPeer-reviewedCC BYFull textEurope PMC
  4. Plant-Based Functional Formulae Mitigate Western Diet-Induced MASLD by Modulating Hepatic Oxidative Stress, Inflammation as Well as Nrf-2/HO-1 and NF-κB Gene Expression
    Rasha S. Mohamed, Karem Fouda, Noha E. Ibrahim
    Foods (Basel, Switzerland)Peer-reviewedCC BYFull textEurope PMC
  5. Re-Du-Ning Alleviates Airway-Intestinal Inflammation of COPD Rats by Regulating Glycerophospholipid Metabolism and Modulating Gut Microbiome
    Yule Wang, Lanyu Cheng, Chunyan Wang +5
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{jouriani2026potency,
  title = {{The potency of native postbiotics and paraprobiotics in modulating inflammation by affecting the gut–kidney axis}},
  author = {Fatemeh Haririzadeh Jouriani and Mahnaz Torfeh and Fatemeh Ashrafian and Niloofar Rezaie and Mohsen Mohammadi and Shadi Aghamohammad and Mahdi Rohani},
  journal = {Animal Models and Experimental Medicine},
  year = {2026},
  month = aug,
  doi = {10.1002/ame2.70257},
  url = {https://doi.org/10.1002/ame2.70257},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - The potency of native postbiotics and paraprobiotics in modulating inflammation by affecting the gut–kidney axis
AU  - Fatemeh Haririzadeh Jouriani
AU  - Mahnaz Torfeh
AU  - Fatemeh Ashrafian
AU  - Niloofar Rezaie
AU  - Mohsen Mohammadi
AU  - Shadi Aghamohammad
AU  - Mahdi Rohani
PY  - 2026
DA  - 2026/08/04
JO  - Animal Models and Experimental Medicine
DO  - 10.1002/ame2.70257
UR  - https://doi.org/10.1002/ame2.70257
AB  - Background: The gut's impact on kidney health can be observed through its influence on the gut–kidney axis. However, using paraprobiotic and postbiotic agents may improve gut health and kidney function by affecting signaling pathways. This study aims to assess the anti‐inflammatory and autophagy‐inducing properties of native postbiotics and paraprobiotics to enhance kidney health by targeting the gut–kidney axis.  Methods: In this animal experiment, colitis was induced in male C57Bl/6 mice using dextran sulfate sodium (DSS), and mice were treated with postbiotics and paraprobiotics consisting of four Lactobacillus and two Bifidobacterium strains. A quantitative polymerase chain reaction assay was conducted to evaluate the gene expression involved in the autophagy process in the kidney.  Results: A significant decrease in weight and colon length and an increase in disease activity index and pathological changes were observed in the DSS group. However, the paraprobiotic and postbiotic mixtures, with more emphasis on postbiotics, were effective in preventing these changes caused by DSS. Exposure to DSS resulted in the downregulation of autophagy‐related genes, but this difference was not statistically significant. Both the paraprobiotics and postbiotics increased the expression of genes. The postbiotic mixture had a more pronounced effect in increasing the expression of atg7, atg12, and beclin.  Conclusions: Our native postbiotics and paraprobiotics indicated an effective role in reducing inflammation, especially gut and kidney inflammation, through the gut–kidney axis. The administration of these beneficial agents with the least side effects could be considered a suitable complementary treatment for controlling symptoms in patients with inflammatory‐related disease.
SN  - 2096-5451
SN  - 2576-2095
ER  -